ABCB1 and ovarian carcinoma: In ovarian cancer, ferroptosis inducer erastin was proved to dominantly elevate the intracellular ABCB1 levels by restricting its drug-efflux activity, thus reversing ABCB1-mediated docetaxel resistance [28].